Why the study?
Does intravenous nitroglycerin reduce infarct size and improve collateral blood flow in a canine model of acute coronary occlusion?
Population
43 previously instrumented conscious dogs with permanent occlusion of the mid-circumflex coronary artery
Comparison
6-hour intravenous infusions of nitroglycerin to… vs 6-hour intravenous infusions of saline (n=18)
Design
Preclinical
Follow-up
2 days
Authors
Loading...
Hypothesis-generating for nitroglycerin in acute occlusion; prospective human trials needed before clinical adoption.
Does intravenous nitroglycerin reduce infarct size and improve collateral blood flow in a canine model of acute coronary occlusion?
Intravenous nitroglycerin reduces infarct size and improves collateral blood flow in a canine model of acute coronary occlusion, likely via direct vasodilation rather than reduced myocardial oxygen demand.
Jugdutt et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: